PMV Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
ORBIMED ADVISORS LLC | 05/15/2025 | 6.48 M | $7.06 M | 0.00% | 12.46% |
BML CAPITAL MANAGEMENT, LLC | 05/07/2025 | 3.75 M | $4.08 M | 8.10% | 7.21% |
SIO CAPITAL MANAGEMENT, LLC | 05/15/2025 | 3.74 M | $4.07 M | 4.57% | 7.19% |
ARROWMARK COLORADO HOLDINGS LLC | 05/15/2025 | 3.31 M | $3.61 M | -5.69% | 6.37% |
PFM HEALTH SCIENCES, LP | 05/15/2025 | 3.30 M | $3.60 M | 58.80% | 6.36% |
EUCLIDEAN CAPITAL LLC | 05/15/2025 | 2.63 M | $2.86 M | 0.00% | 5.06% |
ALKEON CAPITAL MANAGEMENT LLC | 05/15/2025 | 2.34 M | $2.55 M | -0.06% | 4.51% |
VANGUARD GROUP INC | 05/09/2025 | 2.18 M | $2.37 M | 1.49% | 4.19% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 2.05 M | $2.23 M | -1.52% | 3.94% |
BLACKROCK, INC. | 05/02/2025 | 1.14 M | $1.25 M | -0.18% | 2.20% |
D. E. SHAW & CO., INC. | 05/15/2025 | 949.73 K | $1.04 M | -7.28% | 1.83% |
STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2025 | 630.18 K | $686.90 K | 17.61% | 1.21% |
ALDEBARAN CAPITAL, LLC | 05/13/2025 | 523.55 K | $570.67 K | 4.25% | 1.01% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 505.60 K | $551.10 K | -29.25% | 0.97% |
04/30/2025 | 489.37 K | $533.41 K | 9.79% | 0.94% | |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 430.79 K | $469.69 K | 2.15% | 0.83% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 353.23 K | $385.02 K | -30.33% | 0.68% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/12/2025 | 267.64 K | $291.72 K | -27.85% | 0.52% |
RBF CAPITAL, LLC | 05/15/2025 | 245.56 K | $267.66 K | 0.00% | 0.47% |
STATE STREET CORP | 05/15/2025 | 157.58 K | $171.76 K | 0.00% | 0.30% |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 155.39 K | $169.37 K | -51.14% | 0.30% |
UBS GROUP AG | 05/13/2025 | 152.28 K | $165.99 K | -44.72% | 0.29% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 05/15/2025 | 148.80 K | $162.19 K | -26.37% | 0.29% |
EVOKE WEALTH, LLC | 05/13/2025 | 133.12 K | $145.10 K | 0.00% | 0.26% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 05/15/2025 | 129.91 K | $141.61 K | -75.94% | 0.25% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 126.00 K | $137.37 K | 0.00% | 0.24% |
ASSENAGON ASSET MANAGEMENT S.A. | 04/15/2025 | 115.04 K | $125.39 K | -25.15% | 0.22% |
NORTHERN TRUST CORP | 05/13/2025 | 107.35 K | $117.01 K | 0.01% | 0.21% |
WALLEYE CAPITAL LLC | 05/14/2025 | 101.70 K | $110.85 K | -20.32% | 0.20% |
ADAR1 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 101.01 K | $110.10 K | 0.00% | 0.19% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 90.26 K | $98.39 K | -25.55% | 0.17% |
PANAGORA ASSET MANAGEMENT INC | 05/15/2025 | 89.63 K | $97.70 K | 0.00% | 0.17% |
PNC FINANCIAL SERVICES GROUP, INC. | 05/09/2025 | 62.13 K | $67.73 K | -10.10% | 0.12% |
VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2025 | 35.00 K | $38.15 K | 0.00% | 0.07% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 34.71 K | $37.83 K | -22.13% | 0.07% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 33.60 K | $37.00 K | 0.00% | 0.06% |
HSBC HOLDINGS PLC | 05/14/2025 | 30.89 K | $32.74 K | -20.95% | 0.06% |
BARCLAYS PLC | 05/15/2025 | 30.20 K | $33.00 K | 0.00% | 0.06% |
MORGAN STANLEY | 05/15/2025 | 28.07 K | $30.59 K | -32.80% | 0.05% |
SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 22.90 K | $24.96 K | -34.94% | 0.04% |
SQUAREPOINT OPS LLC | 05/15/2025 | 21.90 K | $23.87 K | -70.01% | 0.04% |
CITIGROUP INC | 05/12/2025 | 19.31 K | $21.05 K | -96.25% | 0.04% |
AMERIPRISE FINANCIAL INC | 05/14/2025 | 18.01 K | $19.63 K | -21.05% | 0.03% |
CITADEL ADVISORS LLC | 05/15/2025 | 14.12 K | $15.39 K | -86.91% | 0.03% |
INDEPENDENT ADVISOR ALLIANCE | 05/12/2025 | 12.50 K | $13.63 K | -0.11% | 0.02% |
JPMORGAN CHASE & CO | 05/12/2025 | 11.45 K | $12.48 K | -53.44% | 0.02% |
GROUP ONE TRADING, L.P. | 05/14/2025 | 11.30 K | $12.31 K | -24.61% | 0.02% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 10.00 K | $10.90 K | 100.00% | 0.02% |
CI PRIVATE WEALTH, LLC | 05/14/2025 | 10.00 K | $10.90 K | 0.00% | 0.02% |
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 05/14/2025 | 2.09 K | $2.28 K | -57.63% | 0.00% |
PMV Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 83 institutional investors and hedge funds held shares of PMV Pharmaceuticals, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 6.48 M
BML Capital Management, LLC: 3.75 M
Sio Capital Management, LLC: 3.74 M
ArrowMark Colorado Holdings LLC: 3.31 M
PFM Health Sciences, LP: 3.3 M
Euclidean Capital LLC: 2.63 M
71.84% of PMV Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 41.04 M shares in the last 24 months. This purchase volume represents approximately $45.15 M in transactions.